Gabriel Leung's most recent trade in NovoCure Ltd was a trade of 16,999 Stock Option (Right to Buy) done . Disclosure was reported to the exchange on June 3, 2026.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| NovoCure Ltd | Gabriel Leung | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Jun 2026 | 16,999 | 16,999 | - | - | Stock Option (Right to Buy) | |
| NovoCure Ltd | Gabriel Leung | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Jun 2026 | 11,610 | 101,109 (0%) | 0% | 0 | Ordinary Shares | |
| NovoCure Ltd | Gabriel Leung | Director | Sale of securities on an exchange or to another person at price $ 15.77 per share. | 02 Jun 2026 | 2,945 | 89,499 (0%) | 0% | 15.8 | 46,445 | Ordinary Shares |
| NovoCure Ltd | Gabriel Leung | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Jun 2025 | 16,697 | 16,697 | - | - | Stock Option (Right to Buy) | |
| NovoCure Ltd | Gabriel Leung | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Jun 2025 | 11,215 | 92,444 (0%) | 0% | 0 | Ordinary Shares | |
| NovoCure Ltd | Gabriel Leung | Director | Sale of securities on an exchange or to another person at price $ 17.31 per share. | 03 Jun 2025 | 999 | 81,229 (0%) | 0% | 17.3 | 17,297 | Ordinary Shares |
| NovoCure Ltd | Gabriel Leung | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Jun 2024 | 6,229 | 6,229 | - | - | Stock Option (Right to Buy) | |
| NovoCure Ltd | Gabriel Leung | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Jun 2024 | 4,053 | 83,192 | - | 0 | Restricted Stock Units | |
| NovoCure Ltd | Gabriel Leung | Director | Sale of securities on an exchange or to another person at price $ 23.88 per share. | 04 Jun 2024 | 964 | 78,175 (0%) | 0% | 23.9 | 23,025 | Ordinary Shares |
| NovoCure Ltd | Gabriel Leung | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 07 Jun 2023 | 6,277 | 6,277 | - | - | Stock Option (Right to Buy) | |
| NovoCure Ltd | Gabriel Leung | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 07 Jun 2023 | 3,853 | 79,139 | - | 0 | Restricted Stock Units | |
| NovoCure Ltd | Gabriel Leung | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Jun 2022 | 4,350 | 4,350 | - | - | Options to Buy Ordinary Shares | |
| NovoCure Ltd | Gabriel Leung | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Jun 2022 | 2,427 | 75,286 | - | 0 | Restricted Stock Units | |
| NovoCure Ltd | Gabriel Leung | Director | Sale of securities on an exchange or to another person at price $ 152.50 per share. | 05 Aug 2021 | 1,000 | 72,859 (0%) | 0% | 152.5 | 152,500 | Ordinary Shares |
| NovoCure Ltd | Gabriel Leung | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 05 Aug 2021 | 1,000 | 2,345 | - | - | Options to Buy Ordinary Shares | |
| NovoCure Ltd | Gabriel Leung | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 31.45 per share. | 05 Aug 2021 | 1,000 | 73,859 (0%) | 0% | 31.5 | 31,450 | Ordinary Shares |